Le Lézard
Classified in: Health, Business
Subjects: STP, AVO

MI Chamber Applauds House Passage Of Legislation To Repeal And Replace Health Insurance Tax ("HICA"); Encourages Governor's Signature


LANSING, Mich., May 29, 2018 /PRNewswire-USNewswire/ -- Michigan Chamber Vice President of Business Advocacy Wendy Block issued the following statement today in response to State House passage of legislation to repeal and replace Michigan's Health Insurance Claims Tax ("HICA Tax"):

The Michigan Chamber of Commerce is a statewide business organization representing approximately 6,600 employers, trade associations and local chambers of commerce. The Michigan Chamber represents businesses of every size and type in all 83 counties of the state. The Michigan Chamber was established in 1959 to be an advocate for Michigan's job providers in the legislative, political and legal process. (PRNewsFoto/Michigan Chamber of Commerce)

"The Michigan Chamber has long sought legislation to repeal and replace Michigan's wholly unique and uncompetitive Health Insurance Claims Tax, or 'HICA Tax.' The legislation passed by the State Senate and House would allow the state to turn a page on a tax which serves as a disincentive to purchasing health insurance and has added over $1.5 billion to the cost of health insurance coverage since 2011. We urge Governor Snyder to sign this important legislation when it reaches his desk."

"The HICA Tax has proven to be an unstable and inadequate revenue source for the state. The replacement tax, a new Insurance Provider Assessment (IPA), will cut health insurance taxes for employers and individuals and continue to fund Michigan's traditional Medicaid program in a fair and stable way."

"The Michigan Chamber fully supports this legislation because it would create a tax cut for employers purchasing health insurance for their employees as well as individuals purchasing their own coverage."

Senate Bills 992-94 would establish the IPA tax and assess a tax on health insurers on a per-member-per-month (PMPM) basis, which would be passed along to health insurance purchasers. Commercial policies would be assessed a flat rate of $2.40 per member per month (pmpm), while Medicaid HMO policies would be set annually by the state in an amount sufficient to achieve the required result of the federal statistical test. Self-insured and administrative services only plans would be exempt. While the IPA Tax on commercial policies would be passed on to the health care purchasers, the IPA represents a savings from current HICA pmpm tax loads. The specific savings will vary based on claims experience.  The legislation would specify that the HICA Tax would be repealed as soon as the federal Centers for Medicare & Medicaid Services (CMS) approves the IPA tax, or on October 1, 2018, whichever is later.  

The Michigan Chamber of Commerce is a statewide business organization representing over 6,000 employers, trade associations and local chambers of commerce. The Chamber represents employers of every size and type in all 83 counties of the state. Chamber members employ over one million Michigan residents. The Chamber was established in 1959 to be an advocate for Michigan's job providers in the legislative, political and legal process.

SOURCE Michigan Chamber of Commerce


These press releases may also interest you

18 avr 2024
The 31st Canadian Cancer Society (CCS) Daffodil Ball, which took place this evening at Windsor Station in Montreal, raised $1,474,785 to fund innovative research projects and essential support programs for people living with cancer. The largest...

18 avr 2024
The report titled "Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use - Global Forecast 2024-2030" is now available on...

18 avr 2024
South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue virus infection....

18 avr 2024
The report titled "Progressive Familial Intrahepatic Cholestasis Treatment Market by Drug Type (Cholestyramine, Rifampicin, Ursodeoxycholic Acid), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), End-Users - Global...

18 avr 2024
RevolKa Ltd. (Norio Hamamatsu, President & CEO), a venture-backed biotech company providing a game-changing protein engineering technology platform and La Jolla Institute for Immunology (LJI) (Erica Saphire, President & CEO) agreed to start a...

18 avr 2024
Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved ENTYVIO® (vedolizumab) subcutaneous (SC) administration for maintenance therapy in adults with moderately to severely active Crohn's disease (CD)...



News published on and distributed by: